CoChat

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists

Open access

Abstract

The present study was designed to investigate the effects of different caffeine dietary strategies to compare the impact on athletic performance and cardiac autonomic response. The order of the supplementation was randomly assigned: placebo(4-day)-placebo(acute)/PP, placebo(4-day)-caffeine(acute)/PC and caffeine(4-day)-caffeine(acute)/CC. Fourteen male recreationally-trained cyclists ingested capsules containing either placebo or caffeine (6 mg kg−1) for 4 days. On day 5 (acute), capsules containing placebo or caffeine (6 mg kg−1) were ingested 60 min before completing a 16 km time-trial (simulated cycling). CC and PC showed improvements in time (CC vs PP, Δ − 39.3 s and PC vs PP, Δ − 43.4 s; P = 0.00; ƞ 2 = 0.33) and in output power (CC vs PP, Δ 5.55 w and PC vs PP, Δ 6.17 w; P = 0.00; ƞ 2 = 0.30). At the final of the time-trial, CC and PC exhibited greater parasympathetic modulation (vagal tone) when compared to the PP condition (P < 0.00; ƞ 2 = 0.92). Our study provided evidence that acute caffeine intake (6 mg∙kg−1) increased performance (time-trial) and demonstrated a relevant cardioprotective effect, through increased vagal tone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-03158-2

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) Mean ± SE of V0 (%) at the pre supplementation, pre exercise, and post exercise (i.e., TT-test) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Post was significantly different from other moments. (*) Significantly different from other moments (P < 0.05). (B) Mean ± SE of V1 (%) at the PRE suppl, PRE exerc and POST exercise (i.e., TT-test) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Post was significantly different from other moments. (*) Significantly different from other moments (P < 0.05). (C) Mean ± SE of V2 (%) at the PRE suppl, PRE exerc and POST exercise (i.e., TT-test) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Post was significantly different from other moments (P < 0.05). (*) Significantly different from other moments (P < 0.05).
Figure 1 (A) Mean ± SE of V0 (%) at the pre supplementation, pre exercise, and post exercise (i.e., TT-test) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Post was significantly different from other moments. (*) Significantly different from other moments (P < 0.05). (B) Mean ± SE of V1 (%) at the PRE suppl, PRE exerc and POST exercise (i.e., TT-test) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Post was significantly different from other moments. (*) Significantly different from other moments (P < 0.05). (C) Mean ± SE of V2 (%) at the PRE suppl, PRE exerc and POST exercise (i.e., TT-test) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Post was significantly different from other moments (P < 0.05). (*) Significantly different from other moments (P < 0.05).CC BY · PubMed Central
Figure 2 (A) Mean ± SE of time to execute the TT-test with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (*) Significantly different from other experimental conditions (P < 0.05). (B) Mean ± SE of average power output (W) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC) in three different moments of the TT-test. (*) Significantly different from other experimental conditions (P < 0.05).
Figure 2 (A) Mean ± SE of time to execute the TT-test with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (*) Significantly different from other experimental conditions (P < 0.05). (B) Mean ± SE of average power output (W) with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC) in three different moments of the TT-test. (*) Significantly different from other experimental conditions (P < 0.05).CC BY · PubMed Central
Figure 3 (A) Mean ± SE of V0 (%) at the beginning, midway and final of exercise protocol with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Beggining was significantly different from midway and final of the exercise protocol in all experimental conditions; (Φ) Midway was significantly different from final of the exercise protocol in PC experimental conditions (P < 0.05); (#) Significantly difference between CC and PP experimental conditions at the midway of the exercise protocol (P < 0.05); (*) Significantly different from other experimental conditions (P < 0.05). (B) Mean ± SE of V1 (%) at the beginning, midway and final of exercise protocol with 3 experimental conditions: Placebo–Placebo (PP), Placebo–Caffeine (PC) and Caffeine–Caffeine (CC). (θ) Beggining was significantly different from midway and final of the exercise protocol in all experimental conditions (P < 0.05). (C) Mean ± SE of V2 (%) at the beginning, midway and final of exercise protocol with 3 experimental conditions: Placebo–Placebo (PP), Placebo–Caffeine (PC) and Caffeine–Caffeine (CC). (θ) Beggining was significantly different from midway and final of the exercise protocol in all experimental conditions (P < 0.05); (Φ) Midway was significantly different from final of the exercise protocol in PC experimental conditions (P < 0.05); (δ) Significantly difference among PP and both CC and PC experimental conditions at the final of the exercise protocol (P < 0.05); (*) Significantly different from other experimental conditions (P < 0.05).
Figure 3 (A) Mean ± SE of V0 (%) at the beginning, midway and final of exercise protocol with 3 experimental conditions: Placebo-Placebo (PP), Placebo-Caffeine (PC) and Caffeine-Caffeine (CC). (θ) Beggining was significantly different from midway and final of the exercise protocol in all experimental conditions; (Φ) Midway was significantly different from final of the exercise protocol in PC experimental conditions (P < 0.05); (#) Significantly difference between CC and PP experimental conditions at the midway of the exercise protocol (P < 0.05); (*) Significantly different from other experimental conditions (P < 0.05). (B) Mean ± SE of V1 (%) at the beginning, midway and final of exercise protocol with 3 experimental conditions: Placebo–Placebo (PP), Placebo–Caffeine (PC) and Caffeine–Caffeine (CC). (θ) Beggining was significantly different from midway and final of the exercise protocol in all experimental conditions (P < 0.05). (C) Mean ± SE of V2 (%) at the beginning, midway and final of exercise protocol with 3 experimental conditions: Placebo–Placebo (PP), Placebo–Caffeine (PC) and Caffeine–Caffeine (CC). (θ) Beggining was significantly different from midway and final of the exercise protocol in all experimental conditions (P < 0.05); (Φ) Midway was significantly different from final of the exercise protocol in PC experimental conditions (P < 0.05); (δ) Significantly difference among PP and both CC and PC experimental conditions at the final of the exercise protocol (P < 0.05); (*) Significantly different from other experimental conditions (P < 0.05).CC BY · PubMed Central
Figure 4 Dynamics of data acquisition. Placebo–Placebo (PP), Placebo–Caffeine (PC) and Caffeine–Caffeine (CC) conditions were tested in 16 km time Trial (16 km TT) performance and HRV analysis were done pre supplementation (HRV-SP PRE suppl), post supplementation (HRV-SP POST suppl) during 16 km TT (HRV-TT) and post 16 km TT (HRV-SP Post).
Figure 4 Dynamics of data acquisition. Placebo–Placebo (PP), Placebo–Caffeine (PC) and Caffeine–Caffeine (CC) conditions were tested in 16 km time Trial (16 km TT) performance and HRV analysis were done pre supplementation (HRV-SP PRE suppl), post supplementation (HRV-SP POST suppl) during 16 km TT (HRV-TT) and post 16 km TT (HRV-SP Post).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 15

Metadata

Authors
Sampaio-Jorge, F., Morales, A. P., Pereira, R., Barth, T., & Ribeiro, B. G.
Affiliations
  • Universidade Federal do Rio de Janeiro (BR)
  • Southwest Bahia State University (BR)
Corresponding author
Sampaio-Jorge, Felipe
Venue
Scientific Reports
Published
2021-12-21
Volume
11
Issue
1
Pages
24327-24327
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4200165175
Cited by
15
References
63
Citations by year
2026: 2 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 2
FWCI
1.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
  • Health Sciences › Medicine › Physiology (medical) › Thermoregulation and physiological responses
Keywords
caffeine, athletic performance, cyclists, cycling time trial, output power, cardiac autonomic response, vagal tone, parasympathetic modulation, cardioprotection
MeSH terms
Adult, Central Nervous System Stimulants, Bicycling, Caffeine, Cardiotonic Agents, Double-Blind Method, Heart Rate, Humans, Male, Oxygen Consumption, Exercise, Cross-Over Studies, Athletic Performance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists. https://app.cochat.ai/papers/10.1038/s41598-021-03158-2
The paper
Sampaio-Jorge, F., Morales, A. P., Pereira, R., Barth, T., & Ribeiro, B. G. (2021). Caffeine increases performance and leads to a cardioprotective effect during intense exercise in cyclists. Scientific Reports. https://doi.org/10.1038/s41598-021-03158-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.